Metropolis Healthcare Limited
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.
What Metropolis files
- Others61
- Investor Meet54
- Important33
- Updates23
- PPTs10
- Board Meeting9
Metropolis Healthcare posted solid FY26 results with revenue hitting ₹1,646 Cr (+23.6%), EBITDA ₹401 Cr (+23%), and PAT ₹191 Cr (+19%). This volume-led growth continued into Q1 FY27, with revenue up 17% YoY to ₹450 Cr and EBITDA margin at 25.2% (+210 bps YoY). B2C and rural segments were standout...
Metropolis Healthcare delivered strong Q1FY27 results: Revenue rose 17% YoY to ₹450 Cr, PAT jumped 26% YoY to ₹57 Cr, and EBITDA increased 27% YoY to ₹113 Cr, boosting margins. Growth was primarily volume-driven, with patient volumes up 10% (3.7 Mn) and test volumes climbing 11% (7.8 Mn). B2C revenue...
Metropolis Healthcare (MHL Group) showed strong performance, with Q4FY26 revenue up 23% YoY to ₹425 Cr and FY26 revenue at ₹1,646 Cr (+24% YoY). Profitability surged, with Q4FY26 PAT growing 75% to ₹51 Cr and FY26 PAT up 31% to ₹191 Cr. Organic business EBITDA margins hit 27.2% in Q4....
Metropolis Healthcare (METROPOLIS) delivered strong Q3FY26 performance with Group Revenue up 26% YoY to ₹406 Cr, and PAT soaring 63% YoY to ₹51 Cr. Organic revenue also grew 15% YoY to ₹371 Cr, pushing EBITDA margins to 25.0% (+280 bps). Growth was fueled by preventive wellness (TruHealth) and specialty testing,...
Metropolis Healthcare delivered strong Q2FY26 results! Group revenue jumped 23% YoY to ₹429 Cr, with PAT up 13% to ₹53 Cr. Organic business also showed robust 12% revenue growth. EBITDA margins improved to 25.4% for the group, driven by efficiency and integrating acquisitions like Core Diagnostics. Growth was primarily from...